Estimates show that nearly 200,000 Americans are diagnosed with prostate cancer annually, making it one of the most commonly diagnosed cancers after breast and lung cancer. The survival rate for this particular cancer is high, especially if diagnosed in its early stages. Figures show that when this cancer is diagnosed before it metastasizes, roughly 97% of individuals live at least five years after diagnosis.
However, most individuals with prostate cancer don’t display any symptoms or signs, especially when the disease is still in its early stages. This is why it’s important to know some of the signs of prostate cancer, because this will help you be on the lookout for any changes to your health.
Below are some of the signs that may indicate the presence of prostate cancer.
Burning or painful urination
This condition is referred to as dysuria and is commonly linked to urinary tract infections (“UTIs”). However, it may sometimes be a sign of prostate cancer.
The frequent need to urinate
The presence of a tumor on the prostate can apply pressure on an individual’s urethra and bladder. Therefore, if you feel the need to urinate frequently, particularly at night, you should visit your doctor.
Weak or slow urine flow
It is normal for individuals with prostates to have difficulty urinating as they age. It should be noted that it’s not usually because of prostate cancer. However, if your urine flow stops and starts uncontrollably, you should get your prostate examined.
Prostate pain
Experiencing pain in your prostate area, especially when sitting down, may be a sign of an infection. If you experience unexplained pain, visit your urologist for diagnosis.
Presence of blood in urine
This condition is also known as hematuria. While it may also indicate the presence of a UTI, you should still visit the doctor for a check-up. Avoid self-diagnoses.
Issues with ejaculation
If you find it hard to keep an erection, notice a reduced volume of ejaculation, experience painful ejaculations or have blood in your semen, you should visit a urologist for diagnosis. It should be noted, however, that ejaculation issues can also associated with other health conditions.
Doctors recommend that individuals get screened for prostate cancer as soon as they turn 40, especially if they have a high risk of developing the disease. In addition to this, you are advised to keep in mind that most of the symptoms mentioned above also show up as individuals age, hence the need to make use of some of the diagnostic technology availed by companies such as AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) to get a definitive diagnosis of cancer.
NOTE TO INVESTORS: The latest news and updates relating to AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) are available in the company’s newsroom at https://ibn.fm/ANPC
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Brain tumors, such as glioblastoma, are very hard to treat and even surgery isn’t sufficient…
A new study that is being planned by scientists at the University of Calgary, Canada,…
The company has refiled its Abbreviated New Drug Application (“ANDA”) for KETAFREE(TM), a preservative-free IV…
Izotropic recently published a piece that explores the way AI is redefining breast imaging and…
There is general agreement that the U.S. health care system has issues, but there isn’t…
The closing of the public offering provides the company with critical financial flexibility as it…